serotypes were found. Serotype 06:H16 was the most common, occurring in 29% of the ETEC isolates, usually with LT-ST and CFAIII. Generally, CFA/II was associated with expression of both toxins, CFA/1V was associated with expression of ST, and none of the CFAs was routinely found with LT. We conclude that ETEC from soldiers in the Middle East expressed a variety of antigens and that an effective vaccine will require multiple protective antigens.
Diarrhea is the most frequent health problem among travelers from industrialized countries when visiting tropical or subtropical areas of the world. Approximately one-third of these travelers develop diarrhea (21) . While a number of enteropathogens have been associated with traveler's diarrhea, enterotoxigenic Escherichia coli (ETEC) is the most frequent cause and is often isolated from over half of the cases. ETEC isolates are also a primary cause of diarrhea in infants and young children in developing tropical countries (5, 10, 15a) .
Diarrhea caused by ETEC is also an important illness for military personnel from industrialized countries when they are deployed to less developed countries. The first reports that associated E. coli with traveler's diarrhea were from investigations of outbreaks of diarrhea in British troops stationed in Aden (now part of Yemen) in 1965 (22) and in U.S. troops in Vietnam (4) . E. coli strains of serotype 0148:H28 isolated from individuals at both sites have subsequently been found to be enterotoxigenic. Diarrhea caused by ETEC isolates was a well-documented problem for U.S. forces in Egypt (9, 23, 29) , Swedish soldiers in Cyprus (27) , and U.S. forces in Saudi Arabia in the recent Persian Gulf conflict (Operation Desert Shield) (11) . Investigators in those studies used different techniques to identify enteropathogens, but all document the importance of diarrhea caused by ETEC in deployed troops.
ETEC isolates are identified by their ability to produce heat-labile (LT) and/or heat-stable (ST) enterotoxins (15) . In order to colonize the intestine, ETEC isolates express fimbrial antigens on their surfaces called colonization factor antigens (CFAs) (8, 12 (1, 2, 17-19, 24, 31) .
No vaccine for use against ETEC diarrhea has been licensed or fully developed for human use. However, an oral cholera vaccine composed of killed whole-cell Vibrio cholerae plus the B subunit of cholera toxin provided some protection against LT-and LT-ST-producing strains of ETEC (3, 21) . The basis for protective efficacy lies in the fact that LT is nearly identical to cholera toxin (15) . Although anti-LT immunity is important in prevention of disease, many ETEC isolates produce ST without LT (5, 15a) . ST is poorly antigenic and is unrelated to LT, so other common antigens must be evaluated as potential vaccine components. Both CFAs and O:H antigens have been shown to be protective antigens (7, 14) . To determine which bacterial components would be useful in a vaccine against ETEC, we characterized potential protective antigens (toxins, CFAs, and O:H serotypes) of ETEC isolated from U.S. soldiers with diarrhea while deployed to Egypt and Saudi Arabia. ETEC isolates were obtained from earlier studies (11, 29) on the basis of enterotoxin production. We screened for CFAs using antisera and determined the serotypes. We present here the associations encountered among toxins, CFAs, and (29) and (ii) from 12 health care sites located in diverse geographic regions of northeastern Saudi Arabia during Operation Desert Shield, September to December 1990 (11) .
The ETEC isolates used as controls in the CFA assay were H10407 for CFAII (6), M424C1 for CS1 and CS3 (16) , C9lf for CS2 (25) , E8775 for CS4 and CS6 (32) , and E17018A (20) and E11881C (28, 30) for CS6. CFA expression. Bacteria were inoculated from Dorset egg yolk slants or glycerol stocks made from the slants and were stored at -70°C. They were grown briefly in LB and then replica plated onto CFA agar plates. After incubation at 37°C overnight, colonies were transferred to nitrocellulose membranes and were treated as described previously (32 Table 1 .
Toxins. The distributions of toxins produced from ETEC isolated in Egypt and Saudi Arabia were similar and are given in Table 2 . Both LT and ST toxins were produced in 44% of the isolates, ST alone was produced in 39% of the isolates, and LT alone was produced in 17% of the isolates.
CFAs. The distributions of CFAs were similar in Egypt and Saudi Arabia. In ETEC isolates from both countries (Table 2) , CFA/I was least common, one or more of the CFA/II family of antigens was expressed by one-third of the isolates, the CFA/IV family was expressed in another onethird of the isolates, and almost a quarter of the isolates expressed none of the CFAs detectable by our assays. Individuals in Egypt yielded a larger proportion of ETEC isolates bearing CFAII than did individuals in Saudi Arabia, and the ETEC isolates were scattered over a wider variety of serotypes. A slightly higher proportion of CFA/IV was found in individuals in Saudi Arabia than in individuals in Egypt.
The distributions of CS1 and CS2 in CFA/II isolates and CS4 in CFA/IV isolates are given in Table 2 (24) 54 (29) 20 (11) 13 (7) 12 (6) 6 (3) 5 (3) 5 (3) 5 (3) 4 (2) 4 (2) 4 (2) 3 (2) Antibiotic susceptibility. Summaries of the antibiotic susceptibilities of the ETEC isolates examined in the present study have been reported elsewhere (11, 29) . Except for 0128:H12 and 08:NM isolates, there was no strong association between antibiotic susceptibility patterns and serotype, toxin, or CFA expression. All 11 of the 0128:H12 CFA/I (or CFA-) LT-ST isolates were resistant to all antibiotics tested except quinoline agents. All seven of the 08:NM CFA/IV (CS6) ST isolates were susceptible to all antibiotics tested.
Geographic distribution of ETEC isolates from Saudi Arabia. Unlike the ETEC isolates from 1989 that were from a single group of soldiers in Egypt, the ETEC isolates from VOL. 31, 1993 on 1990 were from a large deployment of troops, with samples collected from multiple locations over a period of 4 months. Because of the wide diversity of samples, the data for Saudi Arabia were evaluated for clusters of similar ETEC strains by location, branch of military service, and month of collection. In general, no common toxin, serotype, or CFA predominated in any of the 12 collection sites, in any branch of the military, or during any of the four monthly periods. However, there was a cluster of 11 cases of multidrugresistant 0128:H12 CFA/I LT-ST from one location in Saudi Arabia during November.
DISCUSSION
The distributions of CFA/II, CFAIIV, and ETEC isolates lacking any of these CFAs were similar in Egypt and Saudi Arabia. However, there was a difference in the CFA/I distribution between the two sample populations. Individuals in Egypt yielded a larger proportion of ETEC isolates bearing CFA/I which were scattered over a wider variety of serotypes. CFA/IV. The other serotypes found to be associated with CFAIIV have been reported by others: 027:H7 CFA/IV ST from Argentina (1) and from Zimbabwe (Rhodesia) and Zaire (17) and 0148:H28 CFA/IV ST in Bangladesh (18) and Argentina (1). 0148:H28 was one of the first ETEC isolates described, initially in Aden from British soldiers (22) and later from U.S. troops in Vietnam (4).
There is evidence that CFAs, LT toxoid, and O:H antigens are protective antigens (3, 7, 14, 21) , and oral vaccines that will carry these antigens are being developed. The data presented here indicate that for vaccines to 
